A mutagenesis method for the addition and deletion of highly repetitive DNA regions: The paradigm of EPIYA motifs in the cagA gene of helicobacter pylori

Helicobacter

Volumn 18, Issue 3, 2013, Pages 229-241

  Papadakos, Konstantinos S ^a   Sougleri, Ioanna S ^a   Mentis, Andreas F ^a   Sgouras, Dionyssios N ^a  

^a HELLENIC PASTEUR INSTITUTE   (Greece)

Author keywords

CagA; EPIYA; Helicobacter pylori; Homologous recombination; Mutagenesis

Indexed keywords

BACTERIAL DNA; CAGA PROTEIN; KANAMYCIN; REPETITIVE DNA;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL GROWTH; BACTERIAL MUTATION; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM MUTANT; BACTERIUM PILUS; BACTERIUM TRANSFORMATION; CAGA GENE; CAMPYLOBACTER JEJUNI; CARBOXY TERMINAL SEQUENCE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; EPITHELIUM CELL; GENE CASSETTE; GENE DELETION; GENE DOSAGE; GENE EXPRESSION; GROWTH RATE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HOMOLOGOUS RECOMBINATION; IMMUNOFLUORESCENCE MICROSCOPY; MOLECULAR CLONING; MUTAGENESIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; SCREENING; STOMACH EPITHELIUM; TYPE IV SECRETION SYSTEM;

AMINO ACID MOTIFS; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; CELL LINE; CULTURE MEDIA; EPITHELIAL CELLS; GASTRIC MUCOSA; HELICOBACTER PYLORI; HUMANS; MUTAGENESIS; RECOMBINATION, GENETIC; REPETITIVE SEQUENCES, AMINO ACID; REPETITIVE SEQUENCES, NUCLEIC ACID; SEQUENCE DELETION;

CAMPYLOBACTER JEJUNI; HELICOBACTER PYLORI;

EID: 84876983603     PISSN: 10834389     EISSN: 15235378     Source Type: Journal    
DOI: 10.1111/hel.12029     Document Type: Article

References (43)

1. Bouvard V, Baan R, Straif K, et al. A review of human carcinogens-Part B: biological agents. Lancet Oncol 2009;10:321-2.
2. Suerbaum S, Josenhans C. Helicobacter pylori evolution and phenotypic diversification in a changing host. Nat Rev Microbiol 2007;5:441-52.
3. Bjorkholm B, Sjolund M, Falk PG, Berg OG, Engstrand L, Andersson DI. Mutation frequency and biological cost of antibiotic resistance in Helicobacter pylori. Proc Natl Acad Sci USA 2001;98:14607-12.
4. Kang J, Blaser MJ. Bacterial populations as perfect gases: genomic integrity and diversification tensions in Helicobacter pylori. Nat Rev Microbiol 2006;4:826-36.
5. Karnholz A, Hoefler C, Odenbreit S, Fischer W, Hofreuter D, Haas R. Functional and topological characterization of novel components of the comB DNA transformation competence system in Helicobacter pylori. J Bacteriol 2006;188:882-93.
6. Hofreuter D, Odenbreit S, Henke G, Haas R. Natural competence for DNA transformation in Helicobacter pylori: identification and genetic characterization of the comB locus. Mol Microbiol 1998;28:1027-38.
7. Ge Z, Taylor DE. H. pylori DNA transformation by natural competence and electroporation. Methods Mol Med 1997;8:145-52.
8. Nomura AM, Perez-Perez GI, Lee J, Stemmermann G, Blaser MJ. Relation between Helicobacter pylori cagA status and risk of peptic ulcer disease. Am J Epidemiol 2002;155:1054-9.
9. Blaser MJ, Perez-Perez GI, Kleanthous H, Cover TL, Peek RM, Stemmermann GN, Nomura A. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 1995;55:2111-5.
10. Blaser MJ, Atherton JC. Helicobacter pylori persistence: biology and disease. J Clin Invest 2004;113:321-33.
11. Atherton JC. The pathogenesis of Helicobacter pylori-induced gastro-duodenal diseases. Annu Rev Pathol 2006;1:63-96.
12. Odenbreit S, Puls J, Sedlmaier B, Gerland E, Fischer W, Haas R. Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion. Science 2000;287:1497-500.
13. Mueller D, Tegtmeyer N, Brandt S, Yamaoka Y, De Poire E, Sgouras D, Wessler S, Torres J, Smolka A, Backert S. c-Src and c-Abl kinases control hierarchic phosphorylation and function of the CagA effector protein in Western and East Asian Helicobacter pylori strains. J Clin Invest 2012;122:1553-66.
14. Hatakeyama M. Oncogenic mechanisms of the Helicobacter pylori CagA protein. Nat Rev Cancer 2004;4:688-94.
15. Backert S, Tegtmeyer N, Selbach M. The versatility of Helico-bacter pylori CagA effector protein functions: The master key hypothesis. Helicobacter 2010;15:163-76.
16. Panayotopoulou EG, Sgouras DN, Papadakos KS, Petraki K, Breurec S, Michopoulos S, Mantzaris G, Papatheodoridis G, Mentis A, Archimandritis A. CagA and VacA polymorphisms are associated with distinct pathological features in Helicobacter pylori-infected adults with peptic ulcer and non-peptic ulcer disease. J Clin Microbiol 2010;48:2237-9.
17. Panayotopoulou EG, Sgouras DN, Papadakos K, Kalliaropoulos A, Papatheodoridis G, Mentis AF, Archimandritis AJ. Strategy to characterize the number and type of repeating EPIYA phosphorylation motifs in the carboxyl terminus of CagA protein in Helicobacter pylori clinical isolates. J Clin Microbiol 2007;45:488-95.
18. Sgouras DN, Panayotopoulou EG, Papadakos K, Martinez-Gonzalez B, Roumbani A, Panayiotou J, vanVliet-Constantinidou C, Mentis AF, Roma-Giannikou E. CagA and VacA polymorphisms do not correlate with severity of histopathological lesions in Helicobacter pylori-infected Greek children. J Clin Microbiol 2009;47:2426-34.
19. Argent RH, Kidd M, Owen RJ, Thomas RJ, Limb MC, Atherton JC. Determinants and consequences of different levels of CagA phosphorylation for clinical isolates of Helicobacter pylori. Gastroenterology 2004;127:514-23.
20. Basso D, Zambon CF, Letley DP, et al. Clinical relevance of Helicobacter pylori cagA and vacA gene polymorphisms. Gastroenterology 2008;135:91-9.
21. Higashi H, Tsutsumi R, Fujita A, Yamazaki S, Asaka M, Azuma T, Hatakeyama M. Biological activity of the Helicobacter pylori virulence factor CagA is determined by variation in the tyrosine phosphorylation sites. Proc Natl Acad Sci USA 2002;99:14428-33.
22. van Vliet AH, Wooldridge KG, Ketley JM. Iron-responsive gene regulation in a campylobacter jejuni fur mutant. J Bacteriol 1998;180:5291-8.
23. Geiser M, Cebe R, Drewello D, Schmitz R. Integration of PCR fragments at any specific site within cloning vectors without the use of restriction enzymes and DNA ligase. Biotechniques 2001;31:88-90, 2.
24. Akopyanz N, Bukanov NO, Westblom TU, Kresovich S, Berg DE. DNA diversity among clinical isolates of Helicobacter-Pylori detected by Pcr-based rapd fingerprinting. Nucleic Acids Res 1992;20:5137-42.
25. Logan RP, Robins A, Turner GA, Cockayne A, Borriello SP, Hawkey CJ. A novel flow cytometric assay for quantitating adherence of Helicobacter pylori to gastric epithelial cells. J Immunol Methods 1998;213:19-30.
26. Fischer W, Windhager L, Rohrer S, Zeiller M, Karnholz A, Hoffmann R, Zimmer R, Haas R. Strain-specific genes of Helicobacter pylori: genome evolution driven by a novel type IV secretion system and genomic island transfer. Nucleic Acids Res 2010;38:6089-101.
27. Mattila P, Korpela J, Tenkanen T, Pitkanen K. Fidelity of DNA synthesis by the Thermococcus litoralis DNA polymerase-an extremely heat stable enzyme with proofreading activity. Nucleic Acids Res 1991;19:4967-73.
28. Pyndiah S, Menard A, Zerbib F, Megraud F. Evaluation of the homologous recombination in Helicobacter pylori. Helicobacter 2005;10:185-92.
29. Kurashima Y, Murata-Kamiya N, Kikuchi K, Higashi H, Azuma T, Kondo S, Hatakeyama M. Deregulation of beta-catenin signal by Helicobacter pylori CagA requires the CagA-multimerization sequence. Int J Cancer 2008;122:823-31.
30. Makarova O, Kamberov E, Margolis B. Generation of deletion and point mutations with one primer in a single cloning step. Biotechniques 2000;29:970-2.
31. Wang W, Malcolm BA. Two-stage PCR protocol allowing introduction of multiple mutations, deletions and insertions using QuikChange Site-Directed Mutagenesis. Biotechniques 1999;26:680-2.
32. Naito M, Yamazaki T, Tsutsumi R, Higashi H, Onoe K, Yamazaki S, Azuma T, Hatakeyama M. Influence of EPIYA-repeat polymorphism on the phosphorylation-dependent biological activity of Helicobacter pylori CagA. Gastroenterology 2006;130:1181-90.
33. Haas R, Meyer TF, van Putten JP. Aflagellated mutants of Helicobacter pylori generated by genetic transformation of naturally competent strains using transposon shuttle mutagenesis. Mol Microbiol 1993;8:753-60.
34. Hofreuter D, Odenbreit S, Haas R. Natural transformation competence in Helicobacter pylori is mediated by the basic components of a type IV secretion system. Mol Microbiol 2001;41:379-91.
35. Ferrero RL, Cussac V, Courcoux P, Labigne A. Construction of isogenic urease-negative mutants of Helicobacter pylori by allelic exchange. J Bacteriol 1992;174:4212-7.
36. Schweitzer K, Sokolova O, Bozko PM, Naumann M. Helicobacter pylori induces NF-kappaB independent of CagA. EMBO Rep 2010;11:10-1; author reply 1-2.
37. Censini S, Lange C, Xiang Z, Crabtree JE, Ghiara P, Borodovsky M, Rappuoli R, Covacci A. cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc Natl Acad Sci USA 1996;93:14648-53.
38. Lamb A, Li J-D, Hatakeyama M, Peek RM, Blanke SR, Chen L-F. Response: strain-specific activation of NF-[kappa]B by Helicobacter pylori CagA. EMBO Rep 2010;11:11-2.
39. Saadat I, Higashi H, Obuse C, et al. Helicobacter pylori CagA targets PAR1/MARK kinase to disrupt epithelial cell polarity. Nature 2007;447:330-3.
40. Ren S, Higashi H, Lu H, Azuma T, Hatakeyama M. Structural basis and functional consequence of Helicobacter pylori CagA multimerization in cells. J Biol Chem 2006;281:32344-52.
41. Lu HS, Saito Y, Umeda M, Murata-Kamiya N, Zhang HM, Higashi H, Hatakeyama M. Structural and functional diversity in the PAR1b/MARK2-binding region of Helicobacter pylori CagA. Cancer Sci 2008;99:2004-11.
42. Nesic D, Miller MC, Quinkert ZT, Stein M, Chait BT, Stebbins CE. Helicobacter pylori CagA inhibits PAR1-MARK family kinases by mimicking host substrates. Nat Struct Mol Biol 2010;17:130-2.
43. Suzuki M, Mimuro H, Kiga K, et al. Helicobacter pylori CagA phosphorylation-independent function in epithelial proliferation and inflammation. Cell Host Microbe 2009;5:23-34.